Emergent BioSolutions Inc.
EBS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $743M | $1.04B | −28.8% |
| Operating income | $100M | −$109M | |
| Net income | $52.6M | −$191M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $110M | $231M | −52.4% |
| Operating income | −$37.3M | $76.5M | |
| Net income | −$32.7M | $51.2M |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Emergent BioSolutions's revenue in FY2025?
- $743M in FY2025 (Fiscal year ended Dec 31, 2025), −28.8% vs $1.04B a year earlier, per its 10-K filed Feb 2026.
- Was Emergent BioSolutions profitable in FY2025?
- Yes: net income was $52.6M and operating income $100M in FY2025.
- What was Emergent BioSolutions's revenue in Q3 2026?
- $110M (−52.4% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.